CSL meets with US Federal Trade Commissioners regarding Talecris Acquisition

CSL meets with US Federal Trade Commissioners regarding Talecris Acquisition

Melbourne, Australia — 25/05/2009

CSL Limited today announced that Managing Director, Dr Brian McNamee, met with U.S. Federal Trade Commission (FTC) Commissioners in Washington DC on 22 May to discuss CSL's proposed acquisition of Talecris Biotherapeutics, Inc.


Download this release:
  PDF icon CSL meets with US Federal Commissioners regarding Talecris Acquisition (0.84 MB)



 
Media Contacts: 
Dr Rachel David
  Director, Public Affairs
  CSL Limited
  Telephone: +613 9389 1821
  Email: rachel.david@csl.com.au

Tim Duncan
  Hinton & Associates
  Telephone: +613 9600-1979
  Email: tduncan@hintons.com.au


Investor Contact: 
Mark Dehring
  Head of Investor Relations
  CSL Limited
  Telephone: +613 9389 2818
  Email: mark.dehring@csl.com.au
 

© 2016 CSL Limited